These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37017470)

  • 1. Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE.
    Bergenstal RM; Hachmann-Nielsen E; Kvist K; Peters AL; Tarp JM; Buse JB
    Diabetes Technol Ther; 2023 Jun; 25(6):378-383. PubMed ID: 37017470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
    Hay LC; Wilmshurst EG; Fulcher G
    Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Glycemic Outcomes During the MiniMed
    Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
    Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
    [No Abstract]   [Full Text] [Related]  

  • 4. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    J Diabetes Sci Technol; 2024 May; 18(3):660-666. PubMed ID: 36172693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE.
    Klein KR; Franek E; Marso S; Pieber TR; Pratley RE; Gowda A; Kvist K; Buse JB
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34819298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials.
    Piras de Oliveira C; Dellva MA; Bue-Valleskey J; Chang AM; Liao B
    J Diabetes Complications; 2024 Jan; 38(1):108648. PubMed ID: 38035641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia in People with Type 2 Diabetes and CKD.
    Ahmad I; Zelnick LR; Batacchi Z; Robinson N; Dighe A; Manski-Nankervis JE; Furler J; O'Neal DN; Little R; Trence D; Hirsch IB; Bansal N; de Boer IH
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):844-853. PubMed ID: 30996047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
    Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus.
    El Malahi A; Van Elsen M; Charleer S; Dirinck E; Ledeganck K; Keymeulen B; Crenier L; Radermecker R; Taes Y; Vercammen C; Nobels F; Mathieu C; Gillard P; De Block C
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e570-e581. PubMed ID: 34534297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypoglycemia and cardiovascular risk].
    Avogaro A
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically Serious Hypoglycemia Is Rare and Not Associated With Time-in-range in Youth With New-onset Type 1 Diabetes.
    Addala A; Zaharieva DP; Gu AJ; Prahalad P; Scheinker D; Buckingham B; Hood KK; Maahs DM
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3239-3247. PubMed ID: 34265059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DYNAMIC: Dynamic glucose management strategies delivered through a structured education program improves time in range in a socioeconomically deprived cohort of children and young people with type 1 diabetes with a history of hypoglycemia.
    Pemberton JS; Kershaw M; Dias R; Idkowiak J; Mohamed Z; Saraff V; Barrett TG; Krone R; Uday S
    Pediatr Diabetes; 2021 Mar; 22(2):249-260. PubMed ID: 33205572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.
    Miller KM; Kanapka LG; Rickels MR; Ahmann AJ; Aleppo G; Ang L; Bhargava A; Bode BW; Carlson A; Chaytor NS; Gannon G; Goland R; Hirsch IB; Kiblinger L; Kruger D; Kudva YC; Levy CJ; McGill JB; O'Malley G; Peters AL; Philipson LH; Philis-Tsimikas A; Pop-Busui R; Salam M; Shah VN; Thompson MJ; Vendrame F; Verdejo A; Weinstock RS; Young L; Pratley R
    Diabetes Technol Ther; 2022 Jun; 24(6):424-434. PubMed ID: 35294272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.